Aardvark Therapeutics (AARD) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Aardvark Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $145K and 1 sold $395K of AARD stock on the open market.
Get emailed when insiders cluster-buy stocks like AARD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AARD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $395K | 2 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $145K | 2 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Aardvark Therapeutics, Inc. insiders reported open-market purchases totaling $145K, while 1 insider reported sales totaling $395K. 2 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
AARD earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 11, 2026 | +19.6% | None | -13.1%S&P -0.1% | -21.9% |
| May 7, 2026 | +9.7% | None | -7.6%S&P +0.5% | -32.4% |
| Mar 23, 2026 | -29.1% | None | -7.4%S&P +0.7% | +42.4% |
| Nov 13, 2025 | -10.6% | None | -7.5%S&P -1.7% | +45.5% |
| Aug 13, 2025 | -26.1% | None | +12.2%S&P +0.4% | -23.7% |
| May 14, 2025 | +0.2% | None | -10.4%S&P +0.6% | +18.2% |
| Mar 31, 2025 | -26.1% | None | +7.1%S&P +1.0% | +36.7% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 11SEC | Nelson SunSee Remarks | Sell Plan | 62,00035,475 held (−64%) | $5.18 | $321K | -8.1% | — |
| Sep 11SEC | Nelson SunSee Remarks | Sell Plan | 14,75497,475 held (−13%) | $5.00 | $74K | -4.8% | — |
| Dec 12SEC | Tien-li LeeCEO | Buy | 7,0001,551,613 held (+0%) | $14.49 | $101K | -67.1% | — |
| Dec 12SEC | Nelson SunCFO | Buy | 3,000108,484 held (+3%) | $14.40 | $43K | -66.9% | — |
Insiders at Aardvark Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Nelson SunSee Remarks | $43K | $395K | Sep 11, 2026 | — |
| Tien-li LeeCEO | $101K | — | Dec 12, 2025 | — |
AARD stock: common questions
Are Aardvark Therapeutics, Inc. insiders buying AARD stock?
In the past 12 months, 2 insiders reported open-market purchases of AARD worth $145K. The latest was CEO Tien-li Lee bought $101K of AARD at $14.49 — first open-market purchase in our records.
Are Aardvark Therapeutics, Inc. insiders selling AARD stock?
1 insiders reported sales worth $395K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AARD's 52-week range?
Over the past year AARD has traded between $3.48 and $16.59. It last closed at $4.76 on Oct 9, 2026.